335161-24-5O=C(c1cccc2ccccc12)c1cn(CCCCCF)c2ccccc12ALQFAGFPQCBPED-UHFFFAOYSA-NAM2201 is an indolecarboxamide.
DEA NFLIS-Drug Category -> Synthetic Cannabinoids
DEA Schedule I Controlled Substance -> Hallucinogenic substances
Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds
Synthetic Cannabinoids
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Danger
H301 (50%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P264, P270, P271, P301+P316, P304+P340, P316, P319, P321, P330, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
説明AM2201 (Item No. 10707) is an analytical reference material characterized as a synthetic cannabinoid. AM2201 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.
使用AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively. The physiological actions and metabolism of AM2201 have not been characterized. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.[Cayman Chemical]
現在のフィルター条件では反応記録がありません。
読み込み中…
335161-24-5DTXSID50187158CHEMBL3526578CHEBI:185785化学的特性Pale Yellow Solid